Is the literature inconclusive about the harm of HES? We are not sure

Intensive Care Med. 2017 Oct;43(10):1526-1528. doi: 10.1007/s00134-016-4329-0. Epub 2016 Mar 23.

Authors

Miet Schetz¹, Andrew D Shaw², Jean-Louis Vincent³

Affiliations

¹ Division of Cellular and Molecular Medicine, Clinical Department and Laboratory of Intensive Care Medicine, KU Leuven University, Herestraat 49, 3000, Louvain, Belgium. miet.schetz@scarlet.be.
² Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN, USA.
³ Department of Intensive Care, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium.

PMID: 27007103
DOI: 10.1007/s00134-016-4329-0

No abstract available

Publication types

Editorial

MeSH terms

Acute Kidney Injury / chemically induced
Critical Illness / mortality
Critical Illness / therapy
Crystalloid Solutions
Fluid Therapy / methods
Humans
Hydroxyethyl Starch Derivatives / adverse effects*
Hydroxyethyl Starch Derivatives / pharmacology
Intensive Care Units
Isotonic Solutions / administration & dosage
Plasma Substitutes / adverse effects*
Plasma Substitutes / pharmacology
Randomized Controlled Trials as Topic

Substances

Crystalloid Solutions
Hydroxyethyl Starch Derivatives
Isotonic Solutions
Plasma Substitutes